readthroughSign in
CompanyRNANasdaqSan Diego, CA

Atrium Therapeutics

Atrium Therapeutics develops RNA therapeutics for cardiomyopathies using targeted delivery technology combining monoclonal antibodies with siRNA.

SCHEDULE 13G/ANov 16Latest SEC filing
Nov 16Latest story